Navigation Links
Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging
Date:6/2/2008

tries -- from pharmaceutical manufacturing and chemical/petrochemical processing, to medical devices and diagnostics, forensics, and scientific discovery. For more information, visit http://www.axsun.com .

About LightLab Imaging

LightLab Imaging, Inc., based in Westford MA is the world's leading manufacturer of Optical Coherence Tomography for Cardiac and other applications. LightLab is a wholly owned subsidiary of Goodman Co. Ltd. (Jasdaq: 7535), based in Nagoya, Japan. The company was founded in 1998 and has exclusive license to a broad range of OCT applications from MIT and other entities. The LightLab mission is to develop and distribute photonic imaging technologies that improve patient's wellbeing, enhance diagnostic medicine, improve outcomes, and reduce healthcare expenditures. For more information, visit http://www.lightlabimaging.com .


'/>"/>
SOURCE Axsun Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 2Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 3Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 5Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 6Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 7Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 2Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 3Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 4Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 5Young offenders health critical to rehabilitation 49470 1Young offenders health critical to rehabilitation 49470 2Young offenders health critical to rehabilitation 49470 3Green tea may affect prostate cancer progression 8918 1Green tea may affect prostate cancer progression 8918 2Green tea may affect prostate cancer progression 8918 3After Major Ruling on Unsafe Lead Levels in Paint Experts Reveal How You Can Ensure Your Kids Are Safe 49465 1After Major Ruling on Unsafe Lead Levels in Paint Experts Reveal How You Can Ensure Your Kids Are Safe 49465 2